Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00069732 · ClinicalTrials.gov registry record · Phase 2
Study of Two Complementary and Alternative Medical Treatments for Maintenance of Weight Loss
A Phase 2 study, sponsored by Kaiser Permanente.
- Terminated
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
NCT00069732 is a Phase 2 study that was terminated before completion, run by Kaiser Permanente. The registered enrollment target is 90 participants.
The verdict
NCT00069732, a Phase 2 study, was terminated before completion, sponsored by Kaiser Permanente.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
Study Summary
The goal of this study is to pilot test in a group of overweight-obese individuals the feasibility and acceptability and indications of efficacy of two CAM treatments, qigong, and acupressure-TAT, for improving long term maintenance of weight loss.
Interventions
- BEHAVIORAL qigong
- BEHAVIORAL acupressure-TAT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00069732
The ClinicalTrials.gov registry entry for NCT00069732 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which qigong is the first listed.
NCT00069732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00069732 about?
NCT00069732 is a clinical study titled "Study of Two Complementary and Alternative Medical Treatments for Maintenance of Weight Loss". The goal of this study is to pilot test in a group of overweight-obese individuals the feasibility and acceptability and indications of efficacy of two CAM treatments, qigong, and acupressure-TAT, for improving long term maintenance of weight loss.
What is the current status of trial NCT00069732?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 90 participants.
What interventions are being tested in trial NCT00069732?
The interventions under investigation include: qigong (BEHAVIORAL), acupressure-TAT (BEHAVIORAL).
Who is sponsoring clinical trial NCT00069732?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.